STOCK TITAN

Tenet Healthcare Corp SEC Filings

THC NYSE

Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tenet Healthcare Corporation filings document the regulatory record of a healthcare services company with hospital operations, an ambulatory surgery platform and Conifer revenue cycle management services. Its 8-K reports disclose operating results, financial outlook updates, Regulation FD information, material agreements involving Conifer, and debt financing matters tied to senior secured first lien notes and senior notes.

Tenet's proxy and current reports also cover board composition, shareholder voting matters, executive compensation, officer transition agreements, controller and principal accounting officer appointments, equity-award terms, common stock, senior-note securities and related governance disclosures. These filings connect THC's capital structure and management oversight to its Ambulatory, Hospital and Conifer business activities.

Rhea-AI Summary

Tenet Healthcare executive Lisa Y. Foo reported the vesting and conversion of restricted stock units into common shares. On February 24, 2026, 3,800 of her 2025 Restricted Stock Units converted into 3,800 shares of Tenet Healthcare common stock at no exercise price, reflecting an exercise or conversion of a derivative security.

These restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in equal one-third installments on each of the first three anniversaries of the grant date. The first one-third installment vested on February 24, 2026. Following this transaction, she directly holds 53,017 shares of common stock and 7,602 restricted stock units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TENET HEALTHCARE CORP executive Thomas W. Arnst reported equity-based compensation activity. On February 24, 2026, 3,800 of his 2025 Restricted Stock Units were exercised and converted into 3,800 shares of common stock at a stated price of $0.00 per share.

The units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments; the first one-third vested on February 24, 2026. After these transactions, he directly holds 7,602 restricted stock units and 41,585 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tenet Healthcare’s Principal Accounting Officer, Ramsey R. Scott, reported acquiring shares through the vesting of restricted stock units. On February 24, 2026, 443 restricted stock units converted into 443 shares of common stock at a price of $0.00 per share. Following this derivative exercise, Scott directly owned 9,891 shares of common stock and 888 restricted stock units. The units were granted under the 2019 Stock Incentive Plan, vesting in three equal annual installments, with the first third vesting on February 24, 2026 and settled in common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tenet Healthcare director Nadja West reported a charitable stock gift. On the reported date, she transferred 1,515 shares of Tenet Healthcare common stock as a bona fide gift to a charitable donor-advised fund, with no sale proceeds received. After this donation, she directly owned 26,965 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tenet Healthcare EVP and COO Lisa Y. Foo acquired 28,339 shares of common stock through a grant of performance-based restricted stock on February 13, 2026. The award was earned when the Human Resources Committee certified achievement of performance goals for the period from January 1, 2023 to December 31, 2025.

The shares were granted at no cash cost, with a reported price of $0.0000 per share, and increased her directly held common stock to 49,217 shares after the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TENET HEALTHCARE CORP executive Paola M. Arbour, EVP and Chief Information Officer, reported acquiring 18,894 shares of common stock through a grant or award on February 13, 2026. The shares were issued at a stated price of $0.0000 per share, bringing her directly held total to 39,004 shares.

According to the disclosure, this grant represents performance-based restricted stock that was earned when the company’s Human Resources Committee certified that applicable performance targets were achieved for the performance period from January 1, 2023 to December 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tenet Healthcare CEO Saumya Sutaria reported an equity award under the company’s incentive plan. He acquired 245,592 shares of common stock at no cost through a grant of performance-based restricted stock that was earned when the Human Resources Committee certified achievement of performance goals for the period from January 1, 2023 to December 31, 2025. Following this award, his directly held common stock position increased to 620,681 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tenet Healthcare’s principal accounting officer, Ramsey R. Scott, received an equity award. On the reported date, he acquired 9,448 shares of Tenet Healthcare common stock as a grant of performance-based restricted stock at a price of $0 per share.

Following this grant, his directly held common stock totaled 9,448 shares. The award was earned when the company’s Human Resources Committee certified that performance targets were achieved for the performance period from January 1, 2023 to December 31, 2025, based on the extent to which the applicable performance goals were attained.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tenet Healthcare Corp executive Thomas W. Arnst reported an equity award of 37,785 shares of common stock. The Form 4 shows these shares were acquired at a price of $0.00 per share as a grant or award, bringing his directly held common stock to 37,785 shares.

According to the footnote, this represents performance-based restricted stock that was earned when the Human Resources Committee certified achievement of performance targets tied to goals measured over the period from January 1, 2023 to December 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tenet Healthcare Corporation files its annual report describing a large, diversified U.S. healthcare network centered on 50 acute and specialty hospitals and 533 ambulatory surgery centers, plus revenue‑cycle and value‑based care services through Conifer. The company highlights continued investments in higher‑acuity hospital services, new facilities like the 54‑bed Florida Coast Medical Center, and growth in outpatient surgery via USPI joint ventures.

Tenet reports nearly 99,000 employees, significant nurse and physician recruitment challenges, and rising labor costs, including minimum‑wage increases and union activity at 27 hospitals. Management details heavy reliance on managed care, Medicare and Medicaid, noting that policy shifts such as Affordable Care Act subsidy expirations and the new One Big Beautiful Bill Act could reduce coverage, lower supplemental payments and delay government reimbursements. Extensive discussion covers regulatory, antitrust, privacy and cybersecurity obligations, and a formal compliance program aimed at managing fraud‑and‑abuse, HIPAA, and consumer‑protection risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report

FAQ

How many Tenet Healthcare (THC) SEC filings are available on StockTitan?

StockTitan tracks 91 SEC filings for Tenet Healthcare (THC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Tenet Healthcare (THC)?

The most recent SEC filing for Tenet Healthcare (THC) was filed on February 27, 2026.